PTC Therapeutics Gets FDA Complete Response Letter for Vatiquinone NDA

Read more

Santen, RemeGen Ink Licensing Deal for Dual-Target Eye Drug RC28-E

Read more

Madrigal’s Rezdiffra Approved in EU for MASH Treatment

Read more

European Commission Approves OGSIVEO for Adult Desmoid Tumors

Read more

FDA Grants Breakthrough Status to Izalontamab Brengitecan for EGFR-Mutant Lung Cancer

Read more

Boehringer Ingelheim, Palatin Technologies Partner to Develop Melanocortin Receptor Therapy for Retinal Diseases

Read more

Precigen’s PAPZIMEOS Gets Full FDA Approval for Recurrent Respiratory Papillomatosis

Read more

Kexing Biopharm Partners with IQVIA to Drive Global Expansion

Read more

Viatris Receives FDA Approval for First Generic Iron Sucrose Injection in U.S.

Read more

FDA Grants Accelerated Approval to Boehringer’s HERNEXEOS for HER2-Mutant Lung Cancer

Read more